24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Do Immune-Based Cancer Drugs Work Better in Men?Gene Found in Amish Helps Protect Their HeartsOmicron May Overcome Prior COVID InfectionWindy Days Are Safer Days When It Comes to COVID-19Most Vaccinated Adults Plan to Get Boosters: PollStudy Finds Delta Somewhat Resistant to Vaccines — What About Omicron?Is the Mumps Vaccine Becoming Less Effective?Vaping Can Trigger Gene Changes in Cells: StudyPfizer or Moderna? Head-to-Head Study Shows One Shot Has an EdgeSurvivors of Severe COVID Face Doubled Risk for Death a Year LaterKids With Uncontrolled Asthma at Higher Odds for Severe COVID-19Nearly 7% of U.S. Kids Have Had a Head Injury or ConcussionFirst U.S. Omicron Case Reported in California'Ultra-Processed' Foods Up Odds for a Second Heart Attack or StrokeCDC to Toughen COVID Testing for International TravelersAHA News: Irregular Heartbeat Risk Linked to Frequent Alcohol Use in People Under 40Certain Blood Thinners Can Raise Risk of 'Delayed' Bleeding After Head InjuryFDA Panel Gives Support to Merck's COVID Antiviral PillLong-Haul COVID Can Include Chronic Fatigue: StudyVaccines, Boosters Should Protect Against Severe COVID, Even With Omicron: FauciPfizer to Seek FDA Approval of Boosters for Teens Ages 16-17Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron VariantCOVID May Trigger Heart Condition in Young AthletesMany People With High Blood Pressure May Take a Drug That Worsens It: StudyBiden Pushes Vaccines, Masks as Best Defense Against Omicron VariantHow Easily Can Singing Spread COVID-19?New Insights Into What Might Drive Parkinson's DiseaseHot Days Can Send Even Younger Folks to the ERRed Light in Morning May Protect Fading Eyesight: StudyMerck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDAVaccine Makers Already Testing Their Shots Against Omicron VariantWhat Experts Know About the Omicron 'Variant of Concern'Gout Drug Colchicine Won't Help Fight COVID-19What You Need to Know About Stomach CancerFetal Infection With COVID-19 Possible, But UnlikelyCOVID Protection Wanes After 2 Doses of Pfizer Vaccine: StudyRural Hospitals' ERs Just as Effective as Urban Ones: Study1 in 5 Avoided Health Care During Pandemic, Study FindsBoosters: What You Need to KnowAHA News: Pulmonary Embolism Is Common and Can Be Deadly, But Few Know the SignsAlmost 1 in Every 3 College-Age Americans Are Now ObeseAnimal Study Offers Hope for a Vaccine Against Lyme DiseaseAddictive Opioid Painkillers Might Not Be Needed After Knee SurgeryYears of Blood Thinners After Stenting Might Not Be NecessaryU.S. COVID Cases, Hospitalizations on the Rise Just Before ThanksgivingVaping Could Weaken Your Bones, Study FindsWearable Vibration Device May Ease Parkinson's TremorPfizer Says Its COVID Vaccine Provides Full Protection to AdolescentsBooster Shots Prompt Stronger, Longer Protection Than Original Shots: StudyTV Remotes, Nurse Call Buttons: Where Coronavirus Lingers in Nursing Homes
Questions and AnswersLinks
Related Topics

Diabetes

Another Study Finds Pfizer, Moderna Shots Effective Against COVID Variants

HealthDay News
by Robert Preidt
Updated: Oct 15th 2021

new article illustration

FRIDAY, Oct. 15, 2021 (HealthDay News) -- The Moderna and Pfizer COVID vaccines protect against a number of coronavirus variants, including highly contagious Delta, another study confirms.

The findings come as breakthrough infections in vaccinated people raise questions about the vaccines' ability to protect against emerging variants.

The shots do "induce high levels of antibodies against Delta and most variants," said study co-author Akiko Iwasaki, a professor of immunobiology at Yale University. "And two shots are better than one."

Booster shots can also help protect against infection, according to the findings. They were published Oct. 11 in the journal Nature.

For the study, the researchers collected blood samples from 40 health care workers between November 2020 and January 2021, before vaccination.

In the following weeks, more blood samples were collected after volunteers had their first and second doses of the Moderna or Pfizer-BioNTech vaccines.

The blood samples were then exposed to 16 coronavirus variants, including Delta -- currently the most common strain in the United States. Blood collected after vaccination showed enhanced immune response, but it did vary by variant and individual.

In general, immune response was robust against the Delta variant, and even stronger after the participants' second shots.

Delta-related breakthrough infections are not likely to be the result of vaccine failure, according to Iwasaki, but instead due to the variant's extreme infectiousness, which can overwhelm the immune defense.

The researchers also found that people who had COVID prior to vaccination had a stronger immune response after getting their shots than those who had never been infected.

"Recovering from an initial infection is like getting a first vaccine shot," Iwasaki said in a university news release.

A booster shot could have a similar effect, boosting levels of antibodies and T-cells that protect against infection, she suggested.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.

SOURCE: Yale University, news release, Oct. 11, 2021